Cargando…

Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study

PURPOSE: Internal mammary lymph node radiation therapy (IMN-RT) has unclear benefits. Historical data were based on only conventional (2-dimensional) radiation techniques. In this 3-dimensional radiation therapy era, we compared the distant metastasis–free survival (DMFS) rates of patients receiving...

Descripción completa

Detalles Bibliográficos
Autores principales: Jitwatcharakomol, Tanun, Setakoranukul, Jiraporn, Ithimakin, Suthinee, Krittayaphong, Rungroj, Thephamongkhol, Kullathorn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723312/
https://www.ncbi.nlm.nih.gov/pubmed/36483062
http://dx.doi.org/10.1016/j.adro.2022.101072
_version_ 1784844143862743040
author Jitwatcharakomol, Tanun
Setakoranukul, Jiraporn
Ithimakin, Suthinee
Krittayaphong, Rungroj
Thephamongkhol, Kullathorn
author_facet Jitwatcharakomol, Tanun
Setakoranukul, Jiraporn
Ithimakin, Suthinee
Krittayaphong, Rungroj
Thephamongkhol, Kullathorn
author_sort Jitwatcharakomol, Tanun
collection PubMed
description PURPOSE: Internal mammary lymph node radiation therapy (IMN-RT) has unclear benefits. Historical data were based on only conventional (2-dimensional) radiation techniques. In this 3-dimensional radiation therapy era, we compared the distant metastasis–free survival (DMFS) rates of patients receiving IMN-RT with those who did not include coverage of the IMN (non–IMN-RT). This study aimed to determine the relationship between IMN-RT and distant metastasis control in patients with lymph node–positive breast cancer. METHODS AND MATERIALS: This was a single-center retrospective cohort study. Patients were divided into 2 groups: IMN-RT and non–IMN-RT. The criterion of the IMN-RT group was that 80% of the prescribed dose covered ≥98% of the Clinical Target Volume of IMN. The primary outcome was 4-year DMFS, and the secondary outcomes were 4-year overall survival, 4-year disease-free survival, and cardiac toxicity. RESULTS: From January 2012 to December 2018, 570 patients were evaluated (IMN-RT, 143 patients; non–IMN-RT, 427 patients). Propensity score matching decreased the number of patients in each group to 139. The median follow-up was 4.3 years. The 4-year DMFS rates were as follows: IMN-RT, 79.1% (95% confidence interval [CI], 70.1%-85.6%), and non–IMN-RT, 82.8% (95% CI, 74.2%-88.7%; P = .43). The groups’ 4-year overall survival and disease-free survival rates did not differ. The 4-year overall survival rates were 84.3% (95% CI, 76.4%-89.8%) for IMN-RT and 88.1% (95% CI, 81.0%-92.7%; P = .39) for non–IMN-RT. The 4-year disease-free survival rates were 77.1% (95% CI, 68.1%-83.8%) for IMN-RT and 82.1% (95% CI, 73.6%-88.1%; P = .29) for non–IMN-RT. There was no significant difference in cardiac toxicity (IMN-RT, 1.4%; non–IMN-RT, 1.4%; P = 1.0). CONCLUSIONS: In the modern radiation technique era with real-world data, we could not find a benefit of internal mammary irradiation.
format Online
Article
Text
id pubmed-9723312
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97233122022-12-07 Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study Jitwatcharakomol, Tanun Setakoranukul, Jiraporn Ithimakin, Suthinee Krittayaphong, Rungroj Thephamongkhol, Kullathorn Adv Radiat Oncol Scientific Article PURPOSE: Internal mammary lymph node radiation therapy (IMN-RT) has unclear benefits. Historical data were based on only conventional (2-dimensional) radiation techniques. In this 3-dimensional radiation therapy era, we compared the distant metastasis–free survival (DMFS) rates of patients receiving IMN-RT with those who did not include coverage of the IMN (non–IMN-RT). This study aimed to determine the relationship between IMN-RT and distant metastasis control in patients with lymph node–positive breast cancer. METHODS AND MATERIALS: This was a single-center retrospective cohort study. Patients were divided into 2 groups: IMN-RT and non–IMN-RT. The criterion of the IMN-RT group was that 80% of the prescribed dose covered ≥98% of the Clinical Target Volume of IMN. The primary outcome was 4-year DMFS, and the secondary outcomes were 4-year overall survival, 4-year disease-free survival, and cardiac toxicity. RESULTS: From January 2012 to December 2018, 570 patients were evaluated (IMN-RT, 143 patients; non–IMN-RT, 427 patients). Propensity score matching decreased the number of patients in each group to 139. The median follow-up was 4.3 years. The 4-year DMFS rates were as follows: IMN-RT, 79.1% (95% confidence interval [CI], 70.1%-85.6%), and non–IMN-RT, 82.8% (95% CI, 74.2%-88.7%; P = .43). The groups’ 4-year overall survival and disease-free survival rates did not differ. The 4-year overall survival rates were 84.3% (95% CI, 76.4%-89.8%) for IMN-RT and 88.1% (95% CI, 81.0%-92.7%; P = .39) for non–IMN-RT. The 4-year disease-free survival rates were 77.1% (95% CI, 68.1%-83.8%) for IMN-RT and 82.1% (95% CI, 73.6%-88.1%; P = .29) for non–IMN-RT. There was no significant difference in cardiac toxicity (IMN-RT, 1.4%; non–IMN-RT, 1.4%; P = 1.0). CONCLUSIONS: In the modern radiation technique era with real-world data, we could not find a benefit of internal mammary irradiation. Elsevier 2022-09-15 /pmc/articles/PMC9723312/ /pubmed/36483062 http://dx.doi.org/10.1016/j.adro.2022.101072 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Scientific Article
Jitwatcharakomol, Tanun
Setakoranukul, Jiraporn
Ithimakin, Suthinee
Krittayaphong, Rungroj
Thephamongkhol, Kullathorn
Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study
title Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study
title_full Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study
title_fullStr Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study
title_full_unstemmed Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study
title_short Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study
title_sort outcomes of patients with breast cancer treated with or without internal mammary irradiation: a single-center, retrospective propensity score–matched study
topic Scientific Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723312/
https://www.ncbi.nlm.nih.gov/pubmed/36483062
http://dx.doi.org/10.1016/j.adro.2022.101072
work_keys_str_mv AT jitwatcharakomoltanun outcomesofpatientswithbreastcancertreatedwithorwithoutinternalmammaryirradiationasinglecenterretrospectivepropensityscorematchedstudy
AT setakoranukuljiraporn outcomesofpatientswithbreastcancertreatedwithorwithoutinternalmammaryirradiationasinglecenterretrospectivepropensityscorematchedstudy
AT ithimakinsuthinee outcomesofpatientswithbreastcancertreatedwithorwithoutinternalmammaryirradiationasinglecenterretrospectivepropensityscorematchedstudy
AT krittayaphongrungroj outcomesofpatientswithbreastcancertreatedwithorwithoutinternalmammaryirradiationasinglecenterretrospectivepropensityscorematchedstudy
AT thephamongkholkullathorn outcomesofpatientswithbreastcancertreatedwithorwithoutinternalmammaryirradiationasinglecenterretrospectivepropensityscorematchedstudy